company

VITUX PHARMA AS

0667 OSLO

Return on Equity
−0,32 %
Current Ratio
4,84
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue0
Net Income−5 000
Total Assets1 562 000
Total Equity1 544 000
Income (NOK)2022
Revenue0
Expenditure64 000
Operating Profit−64 000
Financial Income59 000
Financial Costs0
Financial Balance59 000
Earnings Before Tax−5 000
Tax0
Net Income−5 000
Balance (NOK)2022
Total Fixed Assets1 470 000
Total Current Assets92 000
Total Assets1 562 000
Total Retained Equity−29 625 000
Total Equity1 544 000
Total Long-Term Debt0
Total Current Debt19 000
Total Equity and Debt1 562 000
Cash flow (NOK)2022
Sales Income0
Other Income0
Revenue0
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure64 000
Operating Profit−64 000
Financial Income59 000
Financial Costs0
Financial Balance59 000
Dividends0
Net Income−5 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets1 470 000
Total Fixed Assets1 470 000
Stock0
Total Investments0
Cash, Bank92 000
Total Current Assets92 000
Total Assets1 562 000
Total Equity1 544 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors19 000
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt19 000
Total Equity and Debt1 562 000
Financial indicators2022
Return on Equity−0,32 %
Debt-to-Equity Ratio0
Operating Profit Margin-
Current Ratio4,84
Quick Ratio4,84
Equity Ratio0,99
Gross Profit Margin-
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English